PrimeraDx
VerifiedMultiplexed infectious disease assays that include scalable target amplification routine technology.
Launch date
Market cap
-
Net debt
-
Enterprise valuation
$80—120m (Dealroom.co estimates Oct 2009.)
Mansfield United States (HQ)
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor investor | $0.0 | round | |
| investor investor investor investor investor investor | $0.0 | round | |
| investor investor investor investor investor | $0.0 | round | |
N/A | Grant | ||
| Total Funding | 000k | ||
Related Content
Recent News about PrimeraDx
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.